Document:

Stock Purchase Agreement

 Exhibit 4.9 
 PURCHASE AGREEMENT 
 THIS STOCK PURCHASE AGREEMENT (the “Agreement”) is
made as of April 30, 2008 by and among (i) Exa Corporation, a Delaware corporation (the “Company”), (ii) Fidelity Ventures Limited (“Fidelity Ventures”) and Fidelity Investors Limited Partnership (“FILP”
and, together with Fidelity Ventures, “Fidelity”), (iii) Boston Capital Ventures III, Limited Partnership (“BCV III”), (iv) Boston Capital Ventures IV, Limited Partnership (“BCV IV” and, together with
Fidelity, the “Principal Investors”), and (v) such additional persons and entities that are holders of the Company’s preferred stock and are Accredited Investors (as defined below) as may become a party to this Agreement in
accordance with the terms hereof (collectively, the “Additional Investors” and, together with BCV III and the Principal Investors, the “Investors”). The Company and the Investors (each individually a “Party”) shall
together be referred to herein as the “Parties.” 
 WHEREAS, the Company issued a non-convertible promissory note to
each of BCV III and BCV IV on February 9, 2004 in the original principal amount of $184,078.10 and $1,168,072.30, respectively (the “Non-Convertible Notes”); 
 WHEREAS, at the Closing (as defined below), BCV III and BCV IV wish to convert the outstanding principal and interest due under the Non-Convertible Notes as of the date of the Closing into the number of
shares of the Company’s Common Stock, par value $0.001 per share (“Common Stock”), and Series I Convertible Preferred Stock, par value $0.001 per share (“Series I Preferred Stock”), set forth on Schedule A under the
heading “Note Shares - Debt Conversion”); 
 WHEREAS, at the Closing, the Principal Investors wish to purchase from
the Company, and the Company wishes to sell to the Principal Investors, the number of shares of Series I Preferred Stock set forth on Schedule A under the heading “Series I Shares - Cash Financing”); 

WHEREAS, at the Closing, the Company wishes to sell to the Additional Investors up to an aggregate of 696,175 shares of Series I
Preferred Stock; and 
 WHEREAS, at the Closing, in addition to the number of Shares of Series I Preferred Stock listed on
Schedule A under the heading “Series I Shares - Cash Financing”, Fidelity Ventures wishes to purchase from the Company, and the Company wishes to sell to Fidelity Ventures, at the Closing, the aggregate number of shares of Series I
Preferred Stock equal to 696,175 less the number of shares of Series I Preferred Stock, if any, purchased by the Additional Investors at the Closing as provided herein. 
 NOW, THEREFORE, in consideration of the premises and the covenants set forth below, the Parties hereby agree as follows: 
 1. Authorization and Sale of Series I Preferred Stock 
 1.1
Authorization of Series I Preferred Stock. The Company has duly authorized the issuance and sale of up to 3,378,380 shares of Series I Preferred Stock (the “Series I Shares”) pursuant to the terms of this Agreement, which Series I
Shares shall have the rights, privileges, restrictions and conditions set forth in the Company’s amended and restated 
 certificate of
incorporation of the Company in the form attached as Exhibit A (the “Amended and Restated Certificate of Incorporation”). 

 1.2 Series I Shares - Principal Investors. At the Closing, the
Company shall issue and sell to the Principal Investors, and each Principal Investor, acting severally and not jointly, shall acquire from the Company, upon the terms and conditions set forth herein, the number of Series I Shares (the “Initial
Series I Shares”) set forth opposite the name of such Principal Investor on Schedule A under the heading “Series I Shares - Cash Financing.” In consideration of the issuance of the Initial Series I Shares to the Principal
Investors, the Principal Investors shall pay to the Company a purchase price of $1.48 per Series I Share (the “Purchase Price”). 
 1.3 Note Shares; Surrender and Cancellation of Non-Convertible Notes. At the Closing, the Company shall sell and issue to BCV III and BCV IV, and BCV III and BCV IV, acting severally and not
jointly, shall acquire from the Company, upon the terms and conditions set forth herein, the number of shares of Common Stock (at a purchase price of $1.00 per share) and the number of Series I Shares (at the Purchase Price), in addition to the
number of Initial Series I Shares acquired by BCV IV pursuant to Section 1.2 hereof, set forth opposite their respective name on Schedule A under the heading “Note Shares - Debt Conversion” (the “Note Shares”). At the
Closing, BCV III and BCV IV shall surrender the Non-Convertible Notes to the Company for cancellation in consideration of the issuance of the Note Shares, and hereby agree that, upon execution of this Agreement, the Non-Convertible Notes shall be
cancelled with no further act or deed simultaneously with the issuance of the Note Shares. 
 1.4 Additional
Series I Shares. Subject to the terms and conditions of this Agreement, at the Closing, the Company agrees to issue and sell up to an aggregate of 696,175 shares of Series I Preferred Stock (the “Additional Series I Shares”), to one or
more Additional Investors who enter into this Agreement by executing and delivering to the Company one or more counterpart signature pages in the form attached hereto as Attachment I (each, a “Financing Signature Page”). By
executing a Financing Signature Page, each such Additional Investor shall be deemed to be a party to this Agreement and an Investor hereunder, and agrees to purchase that number of Additional Series I Shares as shall be agreed upon between the
Company and each such Additional Investor and as shall be set forth on such Financing Signature Page, at the Purchase Price. In the event that the parties eligible to become Additional Investors (the “Eligible Additional Investors”) do not
purchase all of the Additional Series I Shares at the Closing, the Company will sell and issue to Fidelity Ventures, and Fidelity Ventures agrees to purchase from the Company, the aggregate number of Additional Series I Shares not purchased by the
Eligible Additional Investors at the Closing, at the Purchase Price. 
 1.5 Closings. The closing of the
purchase and sale of the Initial Series I Shares and the Note Shares (the “Closing”) shall take place simultaneously with the execution of this Agreement. The Closing shall take place at the offices of Foley Hoag LLP, Seaport World Trade
Center West, 155 Seaport Boulevard, Boston, Massachusetts 02210 (Fax: (617) 832-7000; Tel: (617) 832-1000), or at such other location as the applicable Parties shall agree upon. 

 1.6 Closing Deliveries. On the date of the Closing, the Company shall
deliver to each Investor a certificate for the Series I Shares (and, in the case of BCV III and BCV IV, a certificate for the shares of Common Stock on account of the conversion of the Non-Convertible Notes) purchased by such Investor at such
Closing (each, a “Stock Certificate”), registered in the name of such Investor, against payment to the Company of the applicable Purchase Price, by wire transfer, check, cancellation of indebtedness or other method acceptable to the
Company. If payment by an Investor is made, in whole or in part, by cancellation of indebtedness, then such Investor shall surrender to the Company for cancellation at the Closing any evidence of such indebtedness or shall execute an instrument of
cancellation in form and substance acceptable to the Company. 
 2. Representations and Warranties of the Company.

 In order to induce the Investors to enter into this Agreement and to purchase the Series I Preferred Stock as contemplated
hereby, except as disclosed by the Company in the Disclosure Schedule attached hereto (the “Disclosure Schedule”), the Company hereby represents and warrants to the Investors that the statements contained in this Section 2 are true,
complete and correct. The Disclosure Schedule shall be arranged in paragraphs corresponding to the numbered and lettered subsections contained in this Section 2. 

2.1 Organization and Corporate Power. Except as set forth on Schedule 2.1, the Company is a corporation duly
organized, validly existing and in good standing under the laws of the State of Delaware and is qualified to do business as a foreign corporation in each jurisdiction where such qualification is required and in which failure to so qualify would have
a material adverse effect on the Company. The Company has all required corporate power and authority to own its property, to carry on its business as presently conducted or contemplated to be conducted and to carry out the transactions contemplated
hereby. The copies of the Certificate of Incorporation and By-laws of the Company, as amended to date, which have been furnished to the Investors by the Company, are correct and complete. 

2.2 Authorization. This Agreement, the Series I Preferred Stock, the Right of First Refusal and Co-Sale Rights
Agreement (as defined in Section 4.9) and any other agreements, instruments, or documents entered into by the Company pursuant to this Agreement, the Series I Preferred Stock or the Right of First Refusal and Co-Sale Rights Agreement
(collectively, the “Transaction Documents”) have been duly executed and delivered by the Company and are the legal, valid and, assuming due execution by the other parties hereto and thereto, binding obligations of the Company, enforceable
in accordance with their terms subject to applicable bankruptcy, fraudulent conveyance, insolvency, reorganization, moratorium and similar laws affecting creditors’ rights generally and by general equitable principles. The execution, delivery
and performance of the Transaction Documents have been duly authorized by all necessary corporate action of the Company. 
 2.3 Capitalization. As of the Closing, the entire authorized capital stock of the Company consists of 92,165,000 shares of Common Stock, of which 2,167,501 shares are issued and outstanding, and
77,835,000 shares of Preferred Stock, $.001 par value, of which 2,500,000 have been designated Series A Convertible Preferred Stock (“Series A Preferred Stock”), of which 2,421,661 are issued and outstanding, 4,100,000 of which have been
designated Series B Convertible Preferred Stock (“Series B Preferred Stock”), of which 4,063,694 are issued and outstanding, 4,000,000 of which have been designated Series C Convertible Preferred Stock

 
(“Series C Preferred Stock”), of which 2,911,040 are issued and outstanding, 475,000 of which have been designated Series D Convertible Preferred Stock (“Series D Preferred
Stock”), of which none are issued and outstanding, 1,000,000 of which have been designated Series E Convertible Preferred Stock (“Series E Preferred Stock”), of which 750,000 are issued and outstanding, 1,660,000 of which have been
designated Series F Convertible Preferred Stock (“Series F Preferred Stock”), of which 652,174 are issued and outstanding, 25,000,000 of which have been designated Series G Preferred Stock, of which 6,917,366 are issued and outstanding,
35,000,000 of which have been designated Series H Preferred Stock, of which none are issued and outstanding, and 4,100,000 of which have been designated Series I Preferred Stock, of which none are issued and outstanding. The shares of Common Stock,
Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series E Preferred Stock, Series F Preferred Stock and Series G Preferred Stock outstanding have been duly authorized and are validly issued, fully paid and nonassessable.
A complete list of all holders of Common Stock, Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series E Preferred Stock, Series F Preferred Stock, Series G Preferred Stock and the number of such shares held by each
such holder is attached hereto as Schedule 2.3. The Company holds 211,240 shares of Common Stock, 636,941 shares of Series C Preferred Stock and 250,000 shares of Series E Preferred Stock in its treasury. When issued in accordance with the
terms of this Agreement the Series I Preferred Stock (the “Convertible Shares”) and the shares of Common Stock issued as part of the Note Shares (together with the Convertible Shares, the “Issued Shares”) will be duly authorized,
validly issued and outstanding, fully paid and nonassessable. The Company has authorized and reserved for issuance upon conversion of the Initial Series I Shares and the Additional Series I Shares a sufficient number of shares of its Common Stock
(the “Conversion Shares”), and the Conversion Shares will, upon such issuance in accordance with the terms of the Company’s Amended and Restated Certificate of Incorporation be duly authorized, validly issued and outstanding, fully
paid and nonassessable. Except as set forth in Schedule 2.3A, there are no outstanding warrants, options or other rights to purchase or acquire from the Company, or exchangeable for or convertible into, any shares of capital stock of the
Company. Except as provided herein or as set forth in Schedule 2.3A attached hereto, there are no preemptive rights with respect to the issuance or sale by the Company of the Series I Preferred Stock or the Conversion Shares. Except as set
forth in Schedule 2.3A or as provided in the Second Restated Stockholders Agreement dated September 30, 1996 between the Company and certain of its shareholders and the Right of First Refusal and Co-Sale Rights Agreement or as imposed by
applicable securities laws, there are no restrictions on the transfer or voting of any shares of the Company’s capital stock. Other than as set forth herein, there are no existing rights with respect to registration under the Securities Act of
1933, as amended (the “1933 Act”), of any of the Company’s capital stock. The Company has not violated the 1933 Act or any state Blue Sky or securities laws in connection with the issuance of any of its securities. 

2.4 Subsidiaries. Except as set forth on Schedule 2.4, the Company has no subsidiaries and has no
investments in any other corporation or business organization. 
 2.5 Financial Statements. Attached
hereto as Schedule 2.5 are the Company’s unaudited balance sheet as of December 31, 2007 and its unaudited statement of income and cash flows for the fiscal year then ended and its audited balance sheet as of December 31, 2006
and its audited statement of income and cash flows for the fiscal year then ended (the “Financials”). The Financials fairly present the financial position and the results of operations of the Company as of the date and for the periods
indicated in accordance with generally accepted accounting principles, subject to normal year-end adjustments; provided, however, that no notes to the unaudited Financials are included therein. 

 2.6 Absence of Undisclosed Liabilities. Except as and to the extent
reflected or reserved against in the Financials or as set forth in this Agreement or any Schedule to this Agreement and except for liabilities arising in the ordinary course of its business since December 31, 2007, the Company has no material
accrued or contingent liability arising out of any transaction or state of facts existing prior to the date hereof. 
 2.7 Absence of Certain Developments. To the Company’s knowledge, since December 31, 2007, except as disclosed in Schedule 2.7, there has been no (i) material adverse change in
the condition, financial or otherwise, of the business of the Company or in the assets, liabilities, properties, or business, or prospects relating to the business of the Company, (ii) loss, destruction or damage to any property used in the
business of the Company whether or not insured, which loss would have a material adverse affect on the business of the Company, (iii) labor trouble involving the business of the Company or any material change in the personnel or the terms and
conditions of employment of those employed in the business of the Company, (iv) waiver of any valuable right relating to the business of the Company, (v) loan or extension of credit to any officer or employee employed in the business of
the Company or (vi) acquisition or disposition of any material assets used in the business of the Company (or any contract or arrangement therefor), or any other material transaction by the Company otherwise than for fair value in the ordinary
course of business. 
 2.8 Title to Properties. Except as set forth on Schedule 2.8 and other than
(i) any lien in respect of current taxes not yet due and payable and (ii) possible minor liens and encumbrances which do not in any case materially detract from the value of the property subject thereto or materially impair the operations
of the Company, and which have arisen in the ordinary course of the business of the Company and shall be removed within a reasonable period, the Company has good and marketable title to all real property and good title to properties and assets that
appear on the Company’s balance sheet, free and clear of all mortgages, security interests, liens, restrictions or encumbrances. All machinery and equipment included in such properties which is necessary to the business of the Company is in
satisfactory condition and repair except for reasonable wear and tear, and all leases of real or personal property to which the Company is a party are, to the Company’s knowledge, fully effective and afford the Company peaceful and undisturbed
possession of the subject matter of the lease. To the best of the Company’s knowledge, the Company is not in material violation of any zoning, building or safety ordinance, regulation or requirement or other law or regulation applicable to the
operation of owned or leased properties likely to impede the normal operation of the business of the Company, nor has it received any notice of violation with which it has not complied. 

2.9 Tax Matters. Except as disclosed in Schedule 2.9, there are no federal, state, county or local taxes due
and payable with respect to the Company which have not been paid. The provisions for taxes in the Financials are sufficient for the payment of all accrued and unpaid federal, state, county and local taxes of the Company, whether or not assessed or
disputed as of the date of each such balance sheet. There have been no examinations or audits of any tax returns or reports of the Company by any applicable federal, state or local governmental agency. There have been duly filed all federal, state,
county and local tax returns required to have been filed by the Company and there are in effect no waivers of applicable statutes of limitations with respect to taxes for any year. 

 2.10 Contracts and Commitments. Except for the contracts described in
Schedule 2.10 hereto, the Company does not have any contract, obligation or commitment which involves by its terms a commitment in excess of $250,000 and the Company is not a party to any employment contracts (including contracts with any
common law employee, agent or independent contractor), stock redemption or purchase agreements, financing agreements, distribution right agreements, royalty agreements, licenses under which the Company will be licensee, leases of real property,
pension, profit-sharing, retirement or stock option plans. 
 2.11 No Defaults. Except as set forth in
Schedule 2.11, the Company is not in default (which default could have a material adverse effect on the condition, financial or otherwise, of the Company or on its properties, assets, business or prospects) (a) under its Amended and
Restated Certificate of Incorporation or its By-Laws or any note, indenture, mortgage, lease, agreement, contract, purchase order or other instrument, document or agreement to which it is a party or by which it or any of its property is bound or
affected or (b) with respect to any order, writ, injunction or decree of any court or any federal, state, municipal or other governmental department, commission, board, bureau, agency or instrumentality, domestic or foreign of which it has
knowledge. To the Company’s knowledge, there exists no condition, event or act which after notice, lapse of time, or both, could constitute a default under any of the foregoing. Except as disclosed in Schedule 2.11, to the best of the
Company’s knowledge, no third party is in default under any agreement, contract or other instrument, document, or agreement to which the Company is a party or by which it or any of its property is affected, which default could have a material
adverse effect on the condition, financial or otherwise, of the Company or on its properties, assets, business or prospects. 
 2.12 Intellectual Property. To the Company’s knowledge, the Company does not infringe any patent, copyright, or trademark rights of others. To the Company’s knowledge, all technical
information developed and belonging to the Company which has not been patented has been kept confidential. Except as disclosed on Schedule 2.12, the Company owns or has the perpetual right to use all trade secrets, customer lists, processes,
computer software, patents, copyrights and trademarks required for, incident to or included in its products as currently exist and the Company believes that it will be able to develop or acquire such rights necessary for the conduct of its business
as currently proposed. To its knowledge, the Company is not using and has not used any confidential information, trade secrets, or computer software required for its products of any former employer of any of its past or present employees. The
Company has not sold or licensed its technology except for the granting of technology licenses in the ordinary course of business. 
 2.13 Effect of Transactions. The execution, delivery and performance of the Transaction Documents, the issuance, sale and delivery of the Issued Shares and the Conversion Shares, and compliance
with the provisions hereof and thereof by the Company, do not and will not, with or without the passage of time or the giving of notice or both, (a) violate any provision of law, statute, rule or regulation or any ruling, writ, injunction,
order, judgment or decree of any court, administrative agency or other governmental body or (b) conflict with or result in any 

 
breach of any of the terms, conditions or provisions of, or constitute a default (or give rise to any right of termination, cancellation or acceleration) under, or result in the creation of any
lien, security interest, charge or encumbrance upon any of the properties or assets of the Company under the Amended and Restated Certificate of Incorporation or By-Laws of the Company or any note, indenture, mortgage, lease, agreement, contract,
purchase order or other instrument, document or agreement to which the Company is a party or by which it or any of its property is bound or affected. 
 2.14 No Governmental Consent or Approval Recruited. Based in part on the representations made by the Investors in Section 3 of this Agreement, other than federal or state securities law
filings which have been made or which will be made in a timely manner and other than the filing of the Amended and Restated Certificate of Incorporation (which, as of the Closing, has been filed), no authorization, consent, approval or other order
of, declaration to, or filing with, any governmental agency or body is required for or in connection with the valid and lawful authorization, execution and delivery by the Company of the Transaction Documents, or for or in connection with the valid
and lawful authorization, issuance, sale and delivery of the Issued Shares to the Investors, or for or in connection with the valid and lawful authorization, reservation, issuance, sale and delivery to the Investors of the Conversion Shares.

 2.15 Litigation. There is no action, suit, proceeding or investigation pending, or to the knowledge of
the Company, threatened against the Company which questions the validity of the Transaction Documents or the right of the Company to enter into them or to consummate the transactions contemplated hereby or thereby, or which might result, either
individually or in the aggregate, in any material adverse change in the business, assets, conditions, operations, affairs, or, in the reasonable business judgment of the Company, prospects of the Company, financial or otherwise, or any change in the
current equity ownership of the Company, nor is the Company aware that there is any basis for the foregoing. The foregoing includes, without limitation, actions pending or, to the best knowledge of the Company, threatened (or any basis therefor
known to the Company) involving the prior employment of any of the Company’s employees, their use in connection with the Company’s business of any information, creations or techniques allegedly proprietary to any of their former employers
or other persons or entities, or their obligations under any agreements with prior employers or other persons or entities. None of the Company or any of its officers is a party to, or subject to the provisions of, any order, writ, injunction,
judgment or decree of any court or governmental agency or instrumentality. There is no action, suit or proceeding initiated by the Company currently pending or which the Company presently intends to initiate. 

2.16 Securities Laws. Neither the Company nor any other person, firm or corporation acting on its behalf has sold
any of the Series I Preferred Stock or other securities of the Company to, or offered any thereof for sale to, or solicited any offers to purchase any thereof from, or otherwise approached or negotiated (nor will the Company or any other person,
firm or corporation acting on its behalf sell, offer, solicit or otherwise approach or negotiate) in respect thereof with, such number or character of persons in the aggregate, or in such manner, as would result in bringing the Issued Shares or the
Conversion Shares or any part thereof or any other securities of the Company, within the provisions of Section 5 of the 1933 Act. Assuming that the Investors’ representations and warranties contained in Section 3 of this Agreement are
true and correct, the offer, issuance and sale of the Issued Shares and the Conversion Shares are and 

 
will be exempt from the registration and prospectus delivery requirements of the 1933 Act, and have been or will be registered or qualified (or are exempt from registration and qualification)
under the registration, permit or qualification requirements of all applicable state Blue Sky and securities laws. 
 2.17 Business. The Company has all necessary franchises, permits, licenses and other rights and privileges necessary to permit it to own its property and to conduct its business as now being
conducted. The Company is not in violation of any law, regulation, authorization or order of any public authority relevant to the ownership of its properties or the carrying on of the Company’s business which in the aggregate would have a
material adverse effect on the Company. 
 2.18 Brokerage. There are no claims for brokerage commissions
or finder’s fees or similar compensation in connection with the transactions contemplated by this Agreement based on any arrangement made by or on behalf of the Company, and the Company agrees to indemnify and hold the Investors harmless
against any damages incurred as a result of any such claim. 
 2.19 Employees. There are no controversies
or labor troubles pending, or to the best knowledge of the Company after due inquiry, threatened between it and its employees which in the aggregate would have a material adverse effect on the Company. Except as set forth in Schedule 2.19, to
the best of the Company’s knowledge: (a) no employee of the Company is in violation of any material term of any employment contract, patent or other proprietary information disclosure agreement or any other contract or agreement relating
to the right of any such employee to be employed by the Company because of the nature of the business conducted or proposed to be conducted by the Company or for any other reason, and the continued employment by the Company of its respective present
employees will not result in any such violation; (b) no officer or key employee, has any present intention of terminating his or her employment with the Company nor does the Company have any present intention of terminating any such employment;
and (c) the Company has complied in all material respects with all applicable state and federal laws and regulations respecting employment and employment practices, terms and conditions of employment, wages and hours and other laws related to
employment, and there are no arrears in the payments of wages, withholding or social security taxes, unemployment insurance premiums or other similar obligations. Except as set forth in Schedule 2.19, the Company is not a party to any written
agreement or oral agreement which obligates the Company to retain the services of any employee for more than 120 days, with any of its officers or employees with respect to such person’s employment with the Company. 

2.20 Insurance. The Company maintains in full force such types and amounts of insurance issued by issuers of
recognized responsibility insuring the Company with respect to its respective business and properties, in such amounts and against such losses and risks as are appropriate for the Company’s business. 

 2.21 Environmental and Safety Laws. 

(a) As used in this Agreement, the terms “Removal,” “Remedial Action,” “Release,”
“Hazardous Substance” and “National Priorities List” shall have the same meaning as those terms are given in the Comprehensive Environmental Response Compensation and Liability Act (“CERCLA”) and its implementing
regulations, and the terms “Hazardous Waste” and “Solid Waste” shall have the same meaning as those terms are given in the Resource Conservation and Recovery Act, as amended (“RCRA”) and its implementing regulations.

 (b) The ownership, use and operation of the Company’s business has been in compliance in all material
respects with all Federal, state and local environmental and safety laws, including without limitation RCRA, its implementing regulations and all applicable state hazardous waste laws; the Clean Water Act, as amended, its implementing regulations
and all applicable state and local effluent discharge laws; the Clean Air Act, as amended, its implementing regulations and all applicable state and local air emission laws; the Toxic Substances Control Act, as amended, its implementing regulations
and all applicable state and local toxic substance laws; CERCLA, its implementing regulations and all applicable state and local environmental response, compensation and liability laws; the National Environmental Policy Act of 1969 and its
implementing regulations; the Occupational Safety and Health Act, its implementing regulations and all applicable state and local worker safety and health laws; and all such laws concerning particulate emissions, hazard communication, surface water
pollution, groundwater pollution, air pollution, solid wastes, hazardous wastes, hazardous substances, toxic substances, storage, handling, treatment, transportation, spills or other releases, and disposal of any substance, chemicals, materials or
wastes, and exposure to or notification regarding any substance, chemical, material or waste, and the Company has no reason to believe that any claim, action, lawsuit, proceeding, complaint or charge exists or may be brought for violation of any
such laws. 
 (c) To the Company’s knowledge, there has not been, and is not occurring, at the
Company’s facility at 3 Burlington Woods, Burlington, Massachusetts or any facility previously owned or operated by the Company any Release or threatened Release of any Hazardous Substance, Hazardous Waste, Solid Waste or petroleum, including
crude oil or any fraction thereof, nor has the Company any reason to believe such a Release either is occurring or has occurred at any time in the past under its operation. The Company has not applied or disposed of any Hazardous Substance,
Hazardous Waste, Solid Waste or petroleum, including crude oil or any fraction thereof, in any manner which may form the basis for any present or future claim, demand or action seeking investigation, Removal, or Remedial Action at any facility,
site, location or body of water, surface or subsurface, including groundwater or any costs or expenses related thereto. 
 (d) The Company has not sent, arranged for disposal or treatment, arranged with a transporter for transport for disposal or treatment, transported, or accepted for transport any Hazardous Substance,
Hazardous Waste or petroleum, including crude oil or any fraction thereof, to a facility, site or location. 

(e) The Company has not stored, generated or produced any Hazardous Substance, Hazardous Waste, or petroleum in material
violation of any law. 
 (f) To the Company’s knowledge, the facility at 3 Burlington Woods, Burlington,
Massachusetts has been approved by all necessary governmental authorities, and the Company has obtained and is in possession of all material environmental and safety permits and licenses necessary for its business including permits required by local
zoning laws, if any. 

 2.22 Retirement Obligations, etc. Except as disclosed in Schedule
2.22, the Company does not have any pension, retirement or similar plan or obligation, whether of a legally binding nature or in the nature of informal understandings. The Company is not a party to any collective bargaining agreement and, to the
Company’s knowledge after due inquiry, no organizational efforts are presently being made with respect to any of its employees. 
 2.23 Transactions with Affiliates. Except as disclosed in Schedule 2.23, no stockholder, officer or director of the Company nor any “affiliate” or “associate” of such
Persons (as such terms are defined in the rules and regulations promulgated under the 1933 Act) (herein, a “Related Party”) is a party to any transaction with the Company, including, without limitation, any contract, agreement or other
arrangement providing for the rental of real or personal property from, or otherwise requiring payments to, any Related Party. Except as set forth in Schedule 2.23 no employee of the Company nor any Related Party is indebted in an amount
greater than $5,000 to the Company and the Company is not indebted to any such employee or Related Party, except for the reimbursement of expenses in the ordinary course of business. 

2.24 Books and Records. The minute books of the Company contain accurate records of all meetings and other
corporate actions of the Company’s stockholders, Board of Directors and all committees, if any, appointed by its Board of Directors. The Company’s stock ledger is complete and reflects all issuances, transfers, repurchases and
cancellations of shares of capital stock of the Company. The books of account, ledgers, order books, records and documents of the Company accurately reflect all material information relating to its business, the nature, acquisition, maintenance,
location and collection of its assets and the nature of all transactions giving rise to its obligations and its accounts receivable. 
 2.25 Equal Employment Opportunity. To the best of the Company’s knowledge the Company is in material compliance with (a) all applicable laws of the United States and of The Commonwealth
of Massachusetts relating to equal employment opportunity (including, without limitation, Title VII of the Civil Rights Act of 1964, as amended (42 U.S.C. Section 2000e-17), the Age Discrimination in Employment Act of 1967, as amended (29
U.S.C. Sections 621-634), the Equal Pay Act of 1963 (29 U.S.C. Section 206(d)), and any rules, regulations, and administrative orders relating thereto; Mass. Gen. Laws c. 151B, Mass. Gen. Laws c. 149 Section 24A, et seq., and 105A, et
seq., and any rules or regulations relating thereto); and (b) the applicable terms, relating to equal employment opportunity, of any contract, agreement or grant the Company has with, from or relating (by way of subcontract or otherwise) to any
other contract, agreement or grant of, any federal or state governmental unit (“Government Contract”), including, without limitation, any terms required pursuant to Federal Executive Order No. 11246 and Massachusetts Executive Order
No. 74 (both as amended). To the best of the Company’s knowledge, the Company has kept all records required to be kept, and has filed all reports, affirmative action plans and forms (including, without limitation and where applicable, Form
EEO-1) required to be filed pursuant to any such applicable law or the terms of any such Government Contract. The Company has not been subject to any adverse final determination or order with respect to any charge of employment discrimination made
against it, by the United States Equal Employment Opportunity Commission, the Massachusetts Commission Against Discrimination or any other governmental unit (including, without 

 
limitation, any such governmental unit with which it has a Government Contract), and it is not currently, to the Company’s knowledge, subject to any formal proceedings before, or
investigations by, such commissions or governmental units which may lead to such adverse final determination order. 
 2.26 Material Facts. None of this Agreement, the Schedules hereto and furnished contemporaneously herewith, or any other agreement, document, certificate or written statement furnished or to be
furnished to an Investor, through the Closing at which such Investor purchased its shares of Series I Preferred Stock, by or on behalf of the Company in connection with the transactions contemplated hereby contains any untrue statement of a material
fact or omits to state a material fact necessary to make the statements contained therein or herein in light of the circumstances in which they were made not misleading. 
 3. Representations and Warranties and other Agreements of the Investors. 
 3.1 Representations and Warranties. Each Investor hereby represents and warrants that: 
 (a) Authorization. The Investor has full power and authority to execute, deliver and perform this Agreement and the Amended and Restated Right of First Refusal and Co-Sale Rights Agreement and to
acquire the Series I Shares and the Conversion Shares issuable upon conversion thereof; this Agreement and the Right of First Refusal and Co-Sale Rights Agreement constitute the valid and legally binding obligation of the Investor, enforceable
against the Investor in accordance with their respective terms subject to applicable bankruptcy, fraudulent conveyance, insolvency, reorganization, moratorium and similar laws affecting creditors’ rights generally and by general equitable
principles. Each of BCV III and BCV IV further represent and warrant that it has full power and authority to acquire the Note Shares. 
 (b) Purchase Entirely for own Account. The Series I Shares to be received by the Investor and the Conversion Shares received upon conversion of the Series I Shares (collectively, the
“Securities”; provided, however, that for purposes of BCV III and BCV IV, the term “Securities” shall be deemed to include shares of Common Stock issued as part of the Note Shares) will be acquired for investment for the
Investor’s own account, not as a nominee or agent and not with a view to or for sale in connection with the distribution of any part thereof. The Investor has no present intention of selling, granting any participation in, or otherwise
distributing the same, all without prejudice, however, to the Investor’s right at any time to lawfully sell or otherwise dispose of all or any of the Securities. The Investor does not have any contract, undertaking, agreement or arrangement
with any person to sell, transfer, or grant participations to such person or to any third person, with respect to any of the Securities. 
 (c) Restricted Securities. The Investor understands that the Securities may not be sold, transferred, or otherwise disposed of without registration under the 1933 Act, or an exemption therefrom,
and that in the absence of an effective registration statement covering the Securities or an available exemption from registration under the 1933 Act, the Securities must be held indefinitely. In the absence of an effective registration statement
covering the Securities the Investor will sell, transfer, or otherwise dispose of the Securities only in a manner consistent with its representations and agreements set forth herein. 

 (d) Formation. The Investor represents that it was not organized for
the purpose of making an investment in the Company. 
 (e) Suitability. The Investor is an Accredited
Investor as such term is defined in Rule 501(a) promulgated pursuant to the 1933 Act. 
 (f) Financial
Condition. The Investor’s financial condition is such that it is able to bear the risk of holding the Securities for an indefinite period of time. 
 (g) Experience. The Investor has such knowledge and experience in financial and business matters and in making high risk investments of this type that it is capable of evaluating the merits and
risks of the purchase of the Securities. 
 (h) Receipt of Information. The Investor has been furnished
access to the business records of the Company and such additional information and documents as the Investor has requested and has been afforded an opportunity to ask questions of and receive answers from representatives of the Company concerning the
terms and conditions of this Agreement, the purchase of the Securities, the Company’s business, operations, market potential, capitalization, financial condition and prospects, and all other matters deemed relevant by the Investor. 

(i) Brokerage. There are no claims for brokerage commissions or finder’s fees or similar compensation in
connection with the transactions contemplated by this Agreement based on any arrangement or agreement made by or on behalf of the Investor, and the Investor agrees to indemnify and hold the Company harmless against any damages incurred as a result
of any such claims. 
 3.2 Further Limitations on Disposition. 

(a) The Investor further agrees not to make any transfer of all or any portion of the Securities unless and until there is
then in effect a registration statement under the 1933 Act covering such proposed disposition and such disposition is made in accordance with such registration statement and all applicable state securities laws or unless the Investor has received an
opinion of counsel satisfactory to the Company that such registration is not required; provided, however, the Company will not require such opinion of counsel if at the time of such sale the Company is subject to the reporting requirements of either
Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended (the “1934 Act”), such proposed sale is pursuant to Rule 144 as promulgated under the 1933 Act, as amended and such opinion is not required by the relevant
broker-dealer. 
 (b) Notwithstanding the provisions of paragraph (a), the Investor may transfer to a partner (or
members or partners of a partner), subsidiary, shareholder, spouse, child or affiliate of the Investor, trust for the benefit of such Investor’s spouse or child or a charitable organization, if the transferee agrees in writing to be subject to
the terms hereof to the same extent as if such transferee were an original Investor hereunder (such persons or entities hereinafter referred to as “Permitted Transferees”). 

 3.3 Legends. It is understood that the certificates evidencing the
Securities may bear substantially the following legends: 
 (a) “These securities have not been registered
under the Securities Act of 1933 or registered or qualified under any state securities laws. They may not be sold, offered for sale, pledged or hypothecated in the absence of a registration statement in effect with respect to the securities under
such Act and registration or qualification under applicable state securities laws or an opinion of counsel, if required, satisfactory to the Company that such registration or qualification is not required. Furthermore, the securities are subject to
a certain Stock Purchase Agreement dated April 30, 2008 between the Holder and the Company, a copy of which is on file at the Company’s offices.” 
 (b) Any legend required by the laws of any other applicable jurisdiction. 
 (c) Such legends as are required by the Right of First Refusal and Co-Sale Rights Agreement. 
 4. Conditions to the Investor’s Obligations at the Closing. 
 The
obligation of the Investors to purchase the Issued Shares at a Closing under this Agreement is subject to the fulfillment on or before such Closing of each of the following conditions: 

4.1 Representations and Warranties. The representations and warranties of the Company contained in Section 2
shall be true and correct on and as of the date of such Closing with the same effect as though such representations and warranties had been made on and as of the date of such Closing. 

4.2 Performance. The Company shall have performed and complied with all agreements, obligations, and conditions
contained in this Agreement that are required to be performed or complied with by it on or before such Closing. 

4.3 Compliance Certificate. The Chief Executive Officer of the Company shall deliver to the Investors at such
Closing a certificate certifying that the conditions specified in Sections 4.1, 4.2, 4.4 and 4.5 have been fulfilled and stating that there has been no material adverse change in the business affairs, operations, properties, assets, or condition of
the Company or, in the reasonable judgment of the Company, the prospects of the Company since December 31, 2007. 
 4.4 Amendment of Certificate of Incorporation. The Company shall have filed with the Secretary of State of the State of Delaware the Amended and Restated Certificate of Incorporation. 

4.5 Qualifications. All authorizations, approvals, or permits, if any, of any governmental authority or regulatory
body of the United States or of any state that are required in connection with the lawful issuance and sale of the Issued Shares to the Investors pursuant to this Agreement shall have been duly obtained and shall be effective on and as of the
Closing other than those which are not required to be obtained before the Closing. 

 4.6 Proceedings and Documents. All corporate and other proceedings in
connection with the transactions contemplated at the Closing and all documents incident thereto shall be reasonably satisfactory in form and substance to the Investors and they shall have received all such counterpart original and certified or other
copies of such documents as they may reasonably request. 
 4.7 Opinion of Company Counsel. The Investors
shall have received from Foley Hoag LLP, counsel for the Company, an opinion dated as of the Closing in substantially the form attached hereto as Exhibit B. 

4.8 Secretary’s Certificate. The Secretary or an Assistant Secretary of the Company shall deliver to the
Investors at such Closing a certificate, dated as of the Closing, certifying: (a) that attached thereto is a true and complete copy of all waivers obtained from, and resolutions and votes adopted by, the Board of Directors and the Stockholders
of the Company authorizing the execution, delivery and performance of this Agreement and the Right of First Refusal and Co-Sale Rights Agreement, the issuance, sale and delivery of the Issued Shares and reservation, issuance and delivery of the
Conversion Shares; (b) that attached thereto is a true and complete copy of the Amended and Restated Certificate of Incorporation, as in effect on the date of such certification; and (c) to the incumbency and specimen signature of certain
officers of the Company. 
 4.9 Right of First Refusal and Co-Sale Rights Agreement. The Company and
certain stockholders of the Company shall have entered into the Fourth Amended and Restated Right of First Refusal and Co-Sale Rights Agreement substantially in the form of Exhibit C hereto (the “Right of First Refusal and Co-Sale Rights
Agreement”). 
 5. Conditions of the Company’s Obligations at the Closing. 

The obligations of the Company to sell and issue the Issued Shares at a Closing under this Agreement is subject to the fulfillment on or
before such Closing of each of the following conditions: 
 5.1 Representations and Warranties. The
representations and warranties of the Investors contained in Section 3 shall be true and correct on and as of the date of the Closing with the same effect as though such representations and warranties had been made on and as of the date of the
Closing. 
 5.2 Delivery of Non-Convertible Notes. BCV III and BCV IV shall have delivered to the Company
the original Non-Convertible Notes to be converted into the Note Shares. 
 5.3 Right of First Refusal
and Co-Sale Rights Agreement. The Company and certain stockholders of the Company shall have entered into the Right of First Refusal and Co-Sale Rights Agreement. 

 6. Covenants of the Company. Until the earlier of (i) the closing of an
underwritten public offering pursuant to an effective registration statement under the 1933 Act covering the offer and sale of Common Stock for the account of the Company to the public generally in which the aggregate proceeds to the Company are not
less than $25 million which results in the automatic conversion of the Issued Shares (a “Qualified Public Offering”) and, with respect to any Investor, (ii) the first date on which an Investor, any Permitted Transferee or any
Qualified Buyer no longer holds fifty percent (50%) of the Issued Shares (or of the Conversion Shares upon conversion of the Series I Shares): 
 6.1 Financial and Other Information. 
 (a) Accounts and
Reports. The Company will maintain a standard system of accounts in accordance with generally accepted accounting principles consistently applied; 
 (b) Annual Financial Statements. The Company will deliver to each Investor, each Permitted Transferee and each Qualified Buyer: (i) within one hundred and eighty (180) days after the end
of each fiscal year a copy of the audited consolidated and consolidating balance sheet of the Company as of the end of such year, together with audited consolidated and consolidating statements of income and of cash flows of the Company for such
year, all in reasonable detail, prepared in accordance with generally accepted accounting principles, consistently applied, and certified by Grant Thornton LLP or by another independent public accountant of national standing selected by the Audit
Committee of the Board of Directors of the Company; and (ii) copies of all financial statements and reports which the Company shall send to its stockholders or file with the Securities and Exchange Commission or any stock exchange on which any
securities of the Company may be listed. 
 (c) Quarterly Financial Statements and Budgets. The Company
will furnish to each Investor, each Permitted Transferee and each Qualified Buyer: within thirty (30) days after the end of each quarter, other than the last quarter of the fiscal year of the Company, a copy of the consolidated and
consolidating balance sheet of the Company as of the end of such quarter and consolidated and consolidating statements of income and of cash flows of the Company for such quarter, each of the foregoing balance sheets and statements to set forth in
comparative form the corresponding figures for the prior fiscal period, to be in reasonable detail, to be prepared in accordance with generally accepted accounting principles, consistently applied, and to be certified, subject to normal year-end
audit adjustments, by the principal financial officer of the Company that they are true and accurate in all material respects as of their dates; and as soon as possible, but in any event at least thirty (30) days prior to the beginning of each
fiscal year, a budget and operating plan for such fiscal year, each approved by the Company’s Board of Directors, prepared on a quarterly basis, including projected balance sheets and statements of income and changes in financial condition of
the Company for such quarters. 
 (d) Adverse Change: Litigation. The Company will promptly advise each
Investor, each Permitted Transferee and each Qualified Buyer in writing of each suit or proceeding commenced or threatened against the Company which, if adversely determined, would result in a material adverse change in the condition or business,
financial or otherwise, of the Company and of any facts that come to the Company’s attention which question the accuracy or completeness of the representations and warranties contained herein when made. 

 6.2 Confidentiality. Any person or entity receiving information under
Section 6.1 or any of the schedules or exhibits hereto or exercising rights of visitation or inspection granted hereunder shall maintain the confidentiality of all financial, confidential and proprietary information of the Company acquired by
them in exercising such rights. Notwithstanding the preceding sentence, each Investor or any Permitted Transferee or Qualified Buyer may (1) disclose such information when required by law or governmental order or regulation, or when required by
a subpoena or other process, (2) disclose such information to the extent necessary to enforce this Agreement, or (3) disclose such information to its attorneys, accountants, consultants and other professionals, provided that such
individuals are bound by a duty of confidentiality (contractually or otherwise) to the extent necessary to obtain their services in connection with its investment in the Company. Each Investor may also disclose such information to any affiliate of
the Investor, or, to a partner, shareholder or subsidiary of the Investor provided that the requirements of this subsection shall in turn be binding on any such affiliate, partner, shareholder or subsidiary. 

6.3 Insurance. The Company will keep all its insurable properties insured against loss or damage by fire and other
risks in such amounts as are appropriate for the Company’s business; maintain public liability insurance against claims for personal injury, death or property damage suffered by others upon or in or about any premises occupied by it or arising
from equipment owned by the Company and leased to and located upon or in or about any premises occupied by any other person; maintain all such worker’s compensation or similar insurance as may be required under the laws of any state or
jurisdiction in which it may be engaged in business; and maintain such other insurance as is usually maintained by persons engaged in the same or similar business as is the Company. All such insurance shall be maintained against such risks and in at
least such amounts as such insurance is usually carried by persons engaged in the same or similar businesses, and all insurance herein provided for shall be effected and maintained in force under a policy or policies issued by insurers of recognized
responsibility, except that the Company may effect worker’s compensation or similar insurance in respect of operations in any state or other jurisdiction either through an insurance fund operated by such state or other jurisdiction or by
causing to be maintained a system or systems of self-insurance which is in accord with applicable laws. The Company’s executive officers shall periodically report to the Board of Directors on the status of the insurance coverage of the Company.

 6.4 Payment of Taxes; Corporate Existence . The Company will: 

(a) pay and discharge promptly, or cause to be paid and discharged promptly, when due and payable, all taxes, assessments
and governmental charges or levies imposed upon it or upon its income or upon any of its property, real, personal and mixed, or upon any part thereof, as well as all claims of any kind (including claims for labor, materials and supplies) which, if
unpaid might by law become a lien or charge upon its property; provided, however, that the Company shall not be required to pay any tax, assessment, charge, levy or claim if the amount, applicability or validity thereof shall currently be contested
in good faith by appropriate proceedings and if the Company shall have set aside on its books reserves (classified to the extent required by generally accepted accounting principles) deemed by it adequate with respect thereto; and provided further,
that the Company shall have no obligation to make any payments under this paragraph (a) with respect to property subject to leases pursuant to the terms of which the lessees thereof have undertaken to make such payments; 

 (b) do or cause to be done all things necessary to preserve and keep in full
force and effect its corporate existence, rights and franchises, provided, however, that nothing in this paragraph (b) shall (i) prevent the abandonment or termination of the Company’s authorization to do business in any foreign state
or jurisdiction if, in the opinion of the Company’s Board of Directors, such abandonment or termination is in the interest of the Company and not disadvantageous in any material respect to the holders of any Issued Shares or (ii) require
compliance with any law so long as the validity or applicability thereof shall be disputed or contested in good faith; and 
 (c) maintain and keep, or cause to be maintained and kept, its properties in good repair, working order and condition, and from time to time make, or cause to be made, all repairs, renewals and
replacements which in the opinion of the Company are necessary and proper so that the business carried on in connection therewith may be properly and advantageously conducted at all times. 

6.5 Dealings with Affiliates and Others. Other than ordinary and usual compensation arrangements, the Company shall
not (i) enter into any transaction, including, without limitation, any loans or extensions of credit or royalty agreements, with any officers or directors of the Company, or (ii) enter into any transaction with a holder of five percent
(5%) or more of the capital stock of the Company, or any member of their respective families or any corporation or other entity directly or indirectly controlled by one or more of such officers, directors or stockholders or members of their
families, without the prior consent of the members of the Board of Directors elected by the Investors. 
 6.6
Change in Nature of Business. The Company shall not without the prior consent of the members of the Board of Directors elected by the Investors make any material and fundamental change in its product line or its line of business as carried on
at the date hereof or as contemplated in the Company’s business plan delivered to the Investors prior to the date hereof. 
 6.7 Incurrence of Debt, etc. The Company agrees that without the prior consent of the Board of Directors, the Company shall not make any loans or guarantees, enter into any joint venture or invest
in any entity which is not a wholly-owned subsidiary. 
 6.8 Equal Employment Opportunity. The Company
will (a) comply with all applicable laws of the United States and of The Commonwealth of Massachusetts relating to equal employment opportunity, any rules, regulations, administrative orders and Executive Orders relating thereto and the
applicable terms, relating to equal employment opportunity, of any Government Contract; and (b) keep all records required to be kept, and file all reports, affirmative action plans and forms required to be filed pursuant to any such applicable
law or the terms of any such Government Contract; provided, however, the Company shall not be considered to have failed to comply with the foregoing during any period that any matter relating to the Company’s employment practices is being
contested by the Company in appropriate proceedings, or thereafter, if the Company complies with any final determination issued in such proceedings 

 7. Participation Rights in Future Financings. 

7.1 Right of First Refusal. The Company shall, prior to any issuance by the Company of any of its securities (other
than debt securities with no equity feature) (the “Future Shares”), offer to each Investor the right to purchase its Proportionate Percentage (as defined in Section 7.4) of the Future Shares at a price and on the other terms specified
by the Company in writing delivered to the Investor (the “Proposal”). The Proposal by its terms shall remain open and irrevocable for a period of thirty (30) days (the “Exercise Period”). 

7.2 Notice. Notice of an Investor’s intention to accept, in whole or in part, the Proposal made pursuant to
Section 7.1 shall be evidenced by a writing signed by such Investor and delivered to the Company prior to the end of the Exercise Period setting forth that portion of the Future Shares which the Investor elects to purchase (the “Notice of
Purchase”). 
 7.3 Sale to Third Parties. In the event that the Investors elect not to purchase all
(or any part) of the Future Shares, the Company shall have 120 days from the expiration of the Exercise Period to sell all or any part of such Future Shares not purchased by the Investors (the “Refused Future Shares”) to third-party
purchasers, but only upon terms and conditions in all respects (including, without limitation, unit price and interest rates) which are no more favorable to such third-party purchasers or less favorable to the Company than those set forth in the
Proposal. In the event that the Company so sells the Refused Future Shares to such third-party purchasers, the sale to the Investors of Future Shares in respect of which a Notice of Purchase was delivered to the Company by the Investors shall occur
upon the closing of the sale to such third-party purchasers of Refused Future Shares (which closing shall include full payment to the Company). If there are no Refused Future Shares, the sale to the Investors of such Future Shares shall occur within
20 days of the expiration of the Future Shares Exercise Period. In any event, the sale to the Investors of Future Shares shall be on the terms specified in the Proposal. Any Refused Future Shares not purchased by such third-party purchasers within
such 120-day period shall remain subject to this Section 7. 
 7.4 Proportionate Percentage. The term
“Proportionate Percentage” in Section 7.1 shall mean, that percentage figure which expresses the ratio which (i) the number of shares of Common Stock then owned by the Investor bears to (ii) the aggregate number of shares of
Common Stock (a) outstanding and (b) issuable upon conversion or exercise of securities which are then convertible into or exercisable for Common Stock. For purposes of the computation required under this Section 7.4, the Investor
shall be treated as having converted or exercised all securities which are convertible into or exercisable for shares of Common Stock at the rate at which such securities are convertible into or exercisable for Common Stock at the time of such
computation. 
 7.5 Exceptions. Notwithstanding anything to the contrary stated above, the provisions of,
and the right of the Investors under this Section 7 shall not apply to (i) Future Shares issued in connection with stock splits or stock dividends issued on a pro rata basis to the holders of all shares of Common Stock outstanding or
issuable upon conversion of any security which is convertible into Common Stock (the “Common Stock Equivalents”), in accordance with the number of shares of Common Stock and Common Stock Equivalents held by such holder, (ii) Future
Shares issued upon conversion of the Series I Shares, (iii) any sale of Future Shares 

 
pursuant to a Qualified Public Offering, (iv) any sale of Future Shares pursuant to any warrants or arrangements listed in Schedule 2.3A, (v) any sale or grant of Future Shares
by the Company to its employees, consultants, advisory committee members or directors, pursuant to a bona fide employee stock purchase, option or similar benefit plan or other arrangement approved by the Company’s Board of Directors, or
(vi) any sale of Future Shares pursuant to or in connection with an acquisition of securities or assets by the Company which has been approved in advance in writing by the Investor including but not limited to shares issued to business
corporations for strategic purposes. 
 8. Registration Rights. 

8.1 Definitions. As used in this Agreement: 

(a) The term “Registrable Securities” means the shares of Common Stock of any Holder (as defined in
Section 8.2) issued or issuable (i) upon conversion of the Series A Preferred Stock, the Series B Preferred Stock, the Series C Preferred Stock, the Series E Preferred Stock, the Series F Preferred Stock, the Series G Preferred Stock, the
Series H Preferred Stock or the Series I Preferred Stock, (ii) upon exercise of the Company’s Warrant dated April 30, 1993 issued to Fidelity and (iii) shares of Common Stock owned by Messrs. Kim Molvig and Robert Iannucci.

 (b) The term “Holder” means each Investor, each “Investor” under the Series A Preferred
Stock and Warrant Purchase Agreement dated as of April 30, 1993, as amended, the Series B Convertible Preferred Stock Purchase Agreement dated as of November 2, 1994, as amended, the Series C Convertible Preferred Stock Purchase Agreement
dated as of September 30, 1996, as amended, the Series E Convertible Preferred Stock Purchase Agreement dated as of January 28, 1998, as amended, and the Series F Convertible Preferred Purchase Agreement dated as of January 28, 1998,
as amended, and Messrs. Molvig and Iannucci and any Qualified Buyer (as defined below) or Permitted Transferee (as defined below) of all or a portion of the holder’s rights under this Section 8, provided that any Qualified Buyer or
Permitted Transferee must hold at least 25,000 shares (as adjusted for stock splits, stock dividends, etc.). 

(c) The term “Initiating Holders” shall mean any Holder or Holders who in the aggregate are Holders of fifty
percent (50%) or more of the Registrable Securities. 
 (d) The term “Qualified Buyer” shall mean
a purchaser of Preferred Stock or shares of Common Stock issued upon conversion of Preferred Stock in compliance with the purchase agreement or convertible promissory note governing the original issuance of such shares and the Right of First Refusal
and Co-Sale Rights Agreement. 
 (e) The term “Permitted Transferee” shall mean a partner, subsidiary,
shareholder, spouse, child or affiliate of the Holder, a trust for the benefit of such Holder’s spouse or child or a charitable organization, if the transferee agrees in writing to be subject to the terms hereof to the same extent as if such
transferee were an original Investor hereunder. 

 8.2 Demand Registration. 

(a) If, on or after the earlier to occur of December 31, 2009, or the expiration of 180 days after the Company shall
have first offered its securities pursuant to a registration under the 1933 Act, Initiating Holders shall notify the Company in writing that such Holders intend to offer or cause to be offered for sale to the public all or any portion of the
Registrable Securities under such circumstances as would require registration thereof under the 1933 Act or qualification thereof under one or more state securities laws of jurisdictions in which the offer is to be made, the Company will, as
expeditiously as possible, (i) notify Holders other than the Initiating Holders that it has been requested to register Registrable Securities under the 1933 Act pursuant to this Section 8.2, and (ii) use its best efforts to cause such
securities as may be requested by any Holder thereof to be registered under the 1933 Act, if applicable, and registered or qualified under any state securities laws to the extent required (in the opinion of counsel referred to in this
Section 8.2) to permit the sale or other disposition thereof in the manner described by the person requesting such registration. The Holders shall have a total of four such rights to demand registration of Registrable Securities under this
Section 8.2. In addition to the above-described demand registration rights, the holders of Preferred Stock of the Company shall have a total of two rights to demand registration of Registrable Securities held by them under this
Section 8.2. 
 (b) If holders of securities of the Company other than Holders who are entitled, by contract
with the Company, to have such securities included in such a registration (the “Other Holders”) request such inclusion, the Initiating Holders shall offer to include the securities of such other Holders in any registration pursuant to this
Section 8.2. The Company (together with all Holders and Other Holders proposing to include their securities in such registration) shall enter into an underwriting agreement in customary form with the underwriter or representative of the
underwriters (the “Underwriter”) selected to underwrite such offering by a majority in interest of the Initiating Holders, subject to the approval of the Company, which approval shall not be unreasonably withheld. Notwithstanding any other
provision of this Section 8.2, if the underwriter advises the Initiating Holders in writing that marketing factors require a limitation on the number of shares to be underwritten, the Initiating Holders shall so advise all Holders and Other
Holders whose securities would otherwise be underwritten pursuant hereto, and the number of shares of Registrable Securities that may be included in the registration and underwriting shall be allocated among all Holders in proportion, as nearly as
practicable, to the respective amounts of Registrable Securities which they had requested to be included in such registration and underwriting at the time of filing the registration statement, and to the extent that additional shares may be included
in the underwriting, among all Other Holders requesting such inclusion in proportion, as nearly as practicable, to the respective amount of securities which they had requested to be included in such registration and underwriting. No Registrable
Securities or other securities excluded from the underwriting by reason of the Underwriter’s marketing limitations shall be included in such registration. If any Holder or Other Holder who has requested inclusion in such registration as
provided herein disapproves of the terms of the underwriting, such person may elect to withdraw therefrom by written notice to the Company, the Underwriter and the Initiating Holders. The securities so withdrawn shall also be withdrawn from
registration. If the Underwriter has not limited the number of Registrable Securities or other securities to be underwritten, the Company may include its securities for its own account in such registration if the Underwriter so agrees and if the
number of Registrable Securities which would otherwise have been included in such registration and underwriting will not thereby be limited. 

 (c) The registration of Registrable Securities under this Section 8.2
shall be at the Company’s expense, except that Holders and Other Holders participating in a registration pursuant hereto shall pay their pro rata brokerage or underwriting commissions or discounts relating to the sale owned by them; and the
Company shall also pay the fees and expenses of any one special counsel retained by such Holders or Other Holders and except that after the second demand registration under this Section 8.2 demand registrations shall be at the expense of the
Holders participating in the registration. 
 Initiating Holders who exercise a right to demand registration under this
Section 8.2 may withdraw the exercise and cause the Company either not to file or to withdraw the filing of the registration statement at anytime prior to the effectiveness of such statement, provided that: 

(i) If the exercise is so withdrawn prior to filing of the registration statement, then the withdrawal of the exercise
will not be deemed to have been the exercise of a demand registration right; 
 (ii) If effectiveness of the
registration statement is delayed by more than 90 days by the Company and the exercise is withdrawn prior to effectiveness of the registration statement, then the withdrawal of the exercise will not be deemed to have been the exercise of a demand
registration right; 
 (iii) Any withdrawals other than the withdrawals specified in (i) and
(ii) above shall be deemed to be a demand pursuant to Section 8.2 hereof. If the withdrawn demand registration right is not deemed to have been the exercise of a demand registration right, as provided in subparagraphs (i) and
(ii) above, then the withdrawing Holder shall pay or reimburse the legal, auditing and printing expenses reasonably incurred by the Company in connection with the attempted registration; but if the withdrawn demand registration right is deemed
to be an exercise as provided in subparagraph (iii) above, then the Company shall pay all expenses incurred by it in connection with the attempted registration if the Company would have been responsible for paying the expenses of preparation of
such registration statement. 
 8.3 Company Registration. If, at any time, the Company proposes to
register under the 1933 Act, or register or qualify under the laws of any state, any of its Common Stock or securities convertible into or exercisable for Common Stock, on a form under the 1933 Act permitting registration of secondary offerings, it
will each such time give written notice of its intention to do so to each of the Holders. In the case of the registration for the initial public offering of the Company’s stock, the Company will give the Holders at least 30 days prior written
notice of the proposed filing of the registration statement; and in the case of all subsequent registrations, the Company will give the Holders at least 20 days prior written notice of such proposed filing. If a Holder desires to participate in such
registration or qualification of Common Stock, or other securities, it shall notify the Company, within 20 days in the case of the initial registration and 15 days in the case of subsequent registrations, of the number of shares of Registrable
Securities which it desires to have so included. In the event the Company decides to proceed with such registration or qualification, the Company will, at its sole expense, use its best efforts to cause all such Registrable Securities to be
registered or qualified to permit the sale thereof; provided, however, that if, in connection with the offering by the Company of Common 

 
Stock, or securities convertible into or exercisable for Common Stock, pursuant to a registration under the 1933 Act, the underwriter thereof shall impose a limitation on the number of shares of
the Company’s stock or securities which may be included in any such registration statement because, in its judgment, the inclusion of such shares would materially and adversely affect such public offering, then the Company shall be obligated to
include in such registration statement only such portion of the Registrable Securities requested to be registered under this Section 8 as the underwriter permits; provided that all other securities other than those offered for the
Company’s own account shall first be excluded from the registration statement and provided further that not more than 65% of the shares to be included in such registration statement shall be shares to be sold by the Company except that the
Company may include greater than 65% of the shares to be included in such registration to the extent the aggregate of all such shares to be included therein, after allowing therein all securities offered other than by the Company, is less than the
total number of shares permitted to be included by the underwriters. Such limitation will be imposed pro rata with respect to all Registrable Securities as to which inclusion has been requested pursuant to this Section 8.3. The Company shall
bear all of the expense of all registrations pursuant to this Section 8.3, except for the pro rata portion of brokerage or underwriters discounts or commissions relating to the shares sold on behalf of the Holders or Other Holders and the fees
and expenses of any one special counsel retained by such Holders or Other Holders. It shall not be deemed a default of this Agreement if any such underwriter shall (a) establish a limitation on the number of shares allowed to participate in any
public offering of the Company’s stock which are not being sold for the Company’s account (subject to the 65% limitation referred to above), or (b) shall require the holders of the Company’s stock, other than the Company, to
agree to refrain from selling their stock to members of the public for some reasonable period of time (no longer than 180 days, which may be extended upon the request of the managing underwriter for an additional 15 days if the Company issues or
proposes to issue an earnings or other public release within 15 days of the 180 day lock-up period) after the date on which the Company’s stock is first offered to the public (so called lock-up provisions), or (c) shall establish any other
reasonable limitations or restrictions applicable to the holders of the Company’s stock, as a condition to consummating the public offering. 
 8.4 Registration on Form S-3. 
 (a) Following the first
offering of its securities by the Company pursuant to a registration under the 1933 Act, the Company shall use its reasonable efforts to qualify for registration of its Common Stock under the 1933 Act on Form S-3 (or any successor form of similar
tenor and effect). If the Company shall be able to satisfy the conditions for registration of its Common Stock under the 1933 Act on Form S-3 (or any successor form of similar tenor and effect), then, in addition to other rights of the Holders
hereunder, the Company will, upon written request of Holders seeking to register on Form S-3 Registrable Securities having an aggregate market value of at least $500,000, as expeditiously as possible, will use its reasonable best efforts to effect a
registration under the 1933 Act on Form S-3 (or any successor form of similar tenor and effect) of all Registrable Securities referred to in a request or notice given to the Company pursuant to this Section 8.4 and to effect any registration or
qualifications of such Registrable Securities under any state law, and any listing of such Registrable Securities with any securities exchange on which the Common Stock of the Company is then listed, which may be required to permit the sale or
disposition of such Registrable Securities in the manner specified in such request or notices; provided, however, that no more than once per year the 

 
Company may meet its obligations under this Section 8.4 by preparing its own registration of securities on any applicable form under the 1933 Act, which registration becomes effective within
90 days after such request or notice and which registration includes all Registrable Securities referred to in such request or notice. If Registrable Securities sold pursuant to this Section 8.4 are sold in an underwritten offering, the terms
of the underwriting agreement with the underwriter shall be mutually satisfactory to the Company and the Holders requesting registration hereunder. The Company shall not be required to effect more than two registrations pursuant to this
Section 8.4 within any twelve month period. 
 (b) The registration of Registrable Securities under this
Section 8.4 shall be at the Company’s expense, except that Holders participating in a registration pursuant hereto shall pay their pro rata brokerage or underwriting commissions or discounts relating to the sale of Common Stock owned by
them and shall pay the fees and expenses of any one special counsel retained by such Holders or Other Holder. 

8.5 Rule 144 Requirements. Within 90 days following the first offering of its securities by the Company pursuant to
a registration under the 1933 Act, the Company shall become and shall thereafter, so long as is necessary to permit the Holders to sell stock pursuant to Rule 144 under the 1933 Act, or any successor exemptive rule of similar tenor hereafter in
effect (“Rule 144”), remain subject to the reporting requirement of either Section 13 or Section 15(d) of the 1934 Act. At all times when the Company is subject to such reporting requirements, the Company shall use its best
efforts to file with the Securities and Exchange Commission such information as the Commission may require under either of said Sections, and shall exercise its best efforts to take all action as may be required to fulfill the conditions to the
availability of Rule 144 for sales of Common Stock of the Company. The Company shall furnish to each Holder, upon its reasonable request, a written statement executed by the Company as to the steps it has taken to comply with the current public
information requirement of Rule 144. 
 8.6 Transfer Where Registration Not Required. Before transferring,
without registration under the 1933 Act or any state securities laws, any security bearing a legend pursuant to Section 8.5, the Holder thereof shall give written notice to the Company of its intention to do so, describing briefly the manner of
the disposition to be made thereof. Promptly upon receiving such written notice, the Company shall present copies thereof to its counsel and if, in the opinion of such counsel, the proposed disposition of such securities may be effected without
registration or qualification thereof (under all applicable Federal or state laws), the Company, as promptly as practicable, shall notify such Holder of such opinion, whereupon the Holder shall be entitled to dispose of such security in accordance
with the terms of the notice delivered by it to the Company. 
 8.7 Conversion Prior to Sale.
Notwithstanding anything contained herein to the contrary, the obligations of the Company under this Section 8 to effect any registration, qualification, notification, or approval shall be limited to Common Stock only. No Holder shall be
required to convert shares of Preferred Stock to Common Stock prior to requesting any such registration, qualification, notification, or approval, but any such security included therein shall be so converted no later than the date on which such
Holder effects a sale thereof pursuant to such registration, qualification, notification, or approval. 

 8.8 Filing Services of the Company. In connection with any
registration, filings or sales effected under Section 8.2, 8.3 or 8.4 hereof, the Company will: 
 (a)
Prepare and file the registration statement and such amendments and supplements to the registration statement and the prospectus and/or offering circular used in connection therewith as may be necessary to keep the registration statement and/or
notification effective for a period of not less than one hundred and eighty (180) days, as may be necessary for the Holders whose Registrable Securities are registered thereunder to dispose thereof and to comply with the provisions of the 1933
Act and applicable state securities laws with respect to the deposition of the securities covered by the registration statement and/or notification whenever such selling Holder shall dispose of such securities during such period; 

(b) Furnish to such selling Holder, if applicable, such reasonable number of copies of a prospectus or offering circular,
including a preliminary prospectus, in conformity with the requirements of the 1933 Act and regulations thereunder, as such selling Holder may reasonably request in order to facilitate the disposition of such securities; 

(c) Use its best efforts to register or qualify the securities covered by the registration statement under the securities
laws of such jurisdictions as such selling Holder shall reasonably request (to the extent required, in the opinion of counsel referred to in Section 8.6 and provided such filing is not unreasonably burdensome on the Company), and accomplish any
and all other acts which may be reasonably necessary or advisable to enable such selling Holder to consummate the disposition in such jurisdictions of the securities owned by it or him; provided, however that the Company shall not be required to
qualify as a foreign corporation in any such jurisdictions or escrow shares of its capital stock or file any general consent to service of process under the laws of any such jurisdiction; 

(d) Obtain: 
 (i) an opinion of counsel for the Company, dated the effective date of the registration statement, and 
 (ii) “comfort” letters signed by the Company’s independent public accountants who have examined and reported on the Company’s financial statements included in the registration
statement, to the extent permitted by the standards of the AICPA, covering substantially the same matters with respect to the registration statement (and the prospectus included therein) and (in the case of the accountants “comfort”
letters) with respect to events subsequent to the date of the financial statements, as are customarily covered in opinions of issuer’s counsel and in accountants, “comfort” letters delivered to the underwriters in underwritten public
offerings of securities, to the extent that the Company is required to deliver or cause the delivery of such opinion or “comfort” letters to the underwriters in an underwritten public offering of securities; 

(e) Permit each selling Holder or his or its counsel or other representatives to inspect and copy such corporate documents
and records as may reasonably be requested by them; 
 (f) Furnish to each selling Holder a copy of all documents
filed and all correspondence from or to the Securities and Exchange Commission in connection with any such offering; and 

 (g) Indemnify each selling Holder, each officer and director of such Holder
and each person, if any, who controls such Holder, within the meaning of applicable Federal and state securities laws (the “Applicable Securities Laws”) against all losses, claims, damages, liabilities, and expenses (under the Applicable
Securities Laws, or common law or otherwise) resulting from any untrue statement or alleged untrue statement of a material fact contained in any registration statement or prospectus (and as amended or supplemented if the Company shall have furnished
to the selling Holder any amendments or supplements thereto) or resulting from any omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading in light of the
circumstances under which they were made, except insofar as such losses, claims, damages, liabilities or expenses result from any untrue statement or omission contained in information furnished in writing to the Company by the Holder expressly for
use therein. If the offering pursuant to any registration statement provided for under Section 8.2, 8.3 or 8.4 is made by underwriters, the Company agrees to negotiate in good faith the terms of an underwriting agreement with such underwriters and,
to enter into such agreement once the terms thereof are agreed upon and, if required by such terms, to indemnify such underwriters and each person who controls such underwriters within the meaning of the Applicable Securities Laws in substantially
the same manner as hereinabove provided with respect to the indemnification of the selling Holder. In connection with any registration statement in which a Holder is participating, such Holder will furnish to the Company in writing such information
as shall be reasonably requested by the Company for use in any such registration statement or prospectus, will notify the Company as to any changes therein, and will indemnify the Company, its directors, its officers, and each person, if any, who
controls the Company within the meaning of the Applicable Securities Laws, and, if required by the terms of an agreement with such underwriters, such underwriters and each person who controls such underwriters within the meaning of the Applicable
Securities Laws, against any losses, claims, damages, liabilities, and expense resulting from any untrue statement or alleged untrue statement of a material fact or any omission or alleged omission of material fact required to be stated in the
registration statement or prospectus (or any amendment or supplement thereof) and necessary to make the statements therein not misleading in light of the circumstances under which they were made, but only to the extent that such untrue statement or
omission is contained in the information so furnished in writing by the Holder expressly for use therein. 
 (i)
In order to provide for just and equitable contribution to joint liability under the 1933 Act in any case in which either: 
 (1) Any Holder of Registrable Securities exercising rights under this Section 8, or any controlling person of any such person, make a claim for indemnification pursuant to this section but it is
judicially determined (by the entry of a final judgement or decree by a court of competent jurisdiction and the expiration of time to appeal or the denial of the last right of appeal) that such indemnification may not be enforced in such case
notwithstanding the fact that this subsection provides for indemnification in such case; or 
 (2) Contribution
under the 1933 Act may be required on the part of any such selling Holder or any such controlling person in circumstances for which indemnification is provided under this section; 

 then, and in each such case, the Company and such selling Holder will contribute using a relative fault
standard, to the aggregate losses, claims, damages, or liabilities to which they may be subject (after contribution from others) in such proportion so that such selling Holder is responsible for the portion represented by the percentage that the
purchase price of its Common Stock bears to the public offering price of all such Common Stock offered by such registration statement, and the Company is responsible for the remaining portion. 

(ii) Notwithstanding anything to the contrary provided herein, (A) no selling Holder will be required to contribute
or indemnify any amount in excess of the net proceeds received by it from the sale of all such Common Stock offered by it pursuant to such registration statement, and (B) no person or entity guilty of fraudulent misrepresentation (within the
meaning of Section 11(f) of the 1933 Act) will be entitled to contribution or indemnification from any person or entity who was not guilty of such fraudulent misrepresentation. 

(iii) Promptly after receipt by any party to this Agreement of notice of the commencement of any action, suit or
proceeding, such party will, if a claim for contributing in respect thereof is to be made against another party, notify the contributing party of the commencement thereof. The omission to so notify the contributing party will not relieve it from any
liability which it may have to any other party other than for contribution under the 1933 Act. In any case, if such action, suit or proceeding is brought against any party, and such party notifies a contributing party of the commencement thereof,
the contributing party will be entitled to participate therein with the notifying party and any other contributing party similarly notified. The Company shall not be liable for any settlement entered into by any Holder without the Company’s
consent. 
 8.9 Certain Limitation in Connection with Future Grants of Registration Rights. From and after
the date of this Agreement and while any Registrable Securities or securities issued upon conversion thereof remain outstanding, the Company shall not enter into any agreement with any holder or prospective holder of any securities of the Company
which grants to such holder registration rights with respect to any of the Company’s securities unless such agreement provides that: 
 (a) In the reasonable opinion of the Board of Directors of the Company, such rights are no more extensive or favorable to such purchasers than the demand and other registration rights granted to the
Holders; 
 (b) The Holders shall have the right to participate in registrations pursuant to the exercise of such
rights on a pro rata basis; and 
 (c) Such rights relate only to Common Stock of the Company. 

 8.10 Transfer of Registration Rights. Subject to Section 8.1,
the registration rights of a Holder under this Section 8 may be transferred to any Qualified Buyer of all shares of capital stock held by such Holder or Permitted Transferee (including without limitation any partner of any investor which is a
partnership or any estate or trust of which any Investor which is an individual is the grantor) provided, however, that the Company is given written notice by the Holder at the times of such transfer stating the name and address of the transferee
and identifying the securities with respect to which the rights under this Section 8 are being transferred. 

8.11 Exchange Act Registration. If the Company at any time shall list any Common Stock on any national securities
exchange and shall register such Common Stock under the 1934 Act the Company will, at its expense, simultaneously list on such exchange and maintain such listing of, all of the shares of Common Stock included in the definition of Registrable
Securities. 
 8.12 Damages. The Company recognizes and agrees that the selling Holders will not have an
adequate remedy if the Company fails to comply with this Section 8 and that damages will not be readily ascertainable, and the Company expressly agrees that, in the event of such failure, it shall not oppose an application by such selling
Holder or any other person entitled to the benefits of this Section 8 requiring specific performance of any and all provisions hereof or enjoining the Company from continuing to commit any such breach of this Section 8. 

8.13 Termination of Registration Rights. The right of any Holder to request registration or inclusion of
Registrable Securities in any registration pursuant to Section 8 shall terminate upon the earliest to occur of (i) the fifth anniversary of the Company’s first Qualified Public Offering, and (ii) when all of such Holder’s
Registrable Securities could be sold without restriction under Rule 144(b)(1) under the 1933 Act. 
 9. Miscellaneous.

 9.1 Transfers of Certain Rights. Except as otherwise provided for in Section 8 hereof, the rights
granted to an Investor in this Agreement may be transferred by the Investor to a Qualified Buyer or a Permitted Transferee, and by such transferee to a subsequent Qualified Buyer or Permitted Transferee. Any Permitted Transferee or Qualified Buyer
to whom rights under this Agreement are transferred shall (a) as a condition to such transfer, deliver to the Company a written instrument by which such Permitted Transferee or Qualified Buyer agrees to be bound by the obligations imposed upon
the Investor under this Agreement to the same extent as if she, he or it were an Investor under this Agreement and (b) be deemed to be an Investor hereunder. 

9.2 Survival of Representations. The representations and warranties made herein or in any certificates or documents
executed in connection herewith shall survive any investigation made by an Investor and the Closing for a period of one year from the date hereof; and all written statements contained in any certificate or other document delivered by the Company
hereunder or in connection herewith shall be deemed to constitute representations and warranties made by the Company herein. 
 9.3 Incorporation by Reference. All exhibits and schedules appended to this Agreement are herein incorporated by reference and made a part hereof. 

 9.4 Parties in Interest. All covenants, agreements, representations,
warranties and undertakings in this Agreement made by and on behalf of any of the parties hereto shall bind and inure to the benefit of the respective successors and assigns of the parties hereto whether so expressed or not. 

9.5 Amendments and Waivers. Except as set forth in this Agreement, changes in or additions to this Agreement may be
made or compliance with any term, covenant, agreement, condition or provision set forth herein may be omitted or waived (either generally or in a particular instance and either retroactively or prospectively), or representatives to act on behalf of
the holders of all of the Issued Shares may be designated, upon the written consent of the Company and the holders of seventy percent (70%) of the aggregate amount of the shares that would be issued upon conversion of the Series I Preferred
Stock (as if converted on the date of the consent) then outstanding, except that changes to the provisions of Section 8 and the portion of this sentence relating to Section 8 shall be made only upon written approval of holders of at least
sixty-seven percent (67%) of the Registrable Securities. 
 9.6 Governing Law. This Agreement shall
be deemed a contract made under the internal laws of The Commonwealth of Massachusetts and, together with the rights of obligations of the parties hereunder, shall be construed under and governed by the laws of such Commonwealth. 

9.7 Notices. All notices, requests, consents and demands shall be in writing and shall be personally delivered,
mailed, postage prepaid, telecopied or telegraphed, to the Company at: 
 Exa Corporation 

3 Burlington Woods Drive 
 Burlington, Massachusetts 01803 
 Attn: Stephen Remondi 

with a copy to: 

John D. Patterson, Jr., Esq. 
 Foley Hoag LLP 
 Seaport World Trade Center West 

155 Seaport Boulevard 
 Boston, Massachusetts 02210 
 or to the Investors at the addresses set forth on
Schedule A 
 if to Fidelity, with a copy to: 
 Dimitri Racklin, Esq. 
 FMR LLC 

82 Devonshire Street 
 Boston, Massachusetts 02109-3614 

 or such other address as may be furnished in writing to the other parties hereto. All such notices,
requests, demands and other communication shall, when mailed (registered or certified mail, return receipt requested, postage prepaid), personally delivered, or telegraphed, be effective four days after deposit in the mails, when personally
delivered, or when delivered to the telegraph company, respectively, addressed as aforesaid, unless otherwise provided herein and, when telecopied, shall be effective upon actual receipt. 

9.8 Meaning of Share Numbers. Whenever this Agreement refers to a particular number of shares of capital stock of
the Company of any class or series, such number shall be equitably adjusted in the event that after the date hereof the outstanding shares of such class or series shall be (i) increased by way of stock issued as a dividend for no consideration,
(ii) subdivided (by stock split or otherwise) into a greater number of shares or (iii) combined or consolidated, by reclassification or otherwise, into a lesser number of shares. 

9.9 Effect of Headings. The section and paragraph headings herein are for convenience only and shall not affect the
construction hereof. 
 9.10 Entire Agreement. This Agreement and the Exhibits and Schedules hereto
together with any other agreement referred to herein (the “Additional Agreements”) constitute the entire agreement among the Company and the Investors with respect to the subject matter hereof. There are no representations, warranties,
covenants or undertakings with respect to the subject matter hereof other than those expressly set forth herein. This Agreement and such Additional Agreements supersede all prior agreements between the parties with respect to the shares purchased
hereunder and the subject matter hereof. 
 9.11 Severability. The invalidity or unenforceability of any
provision hereof shall in no way affect the validity or enforceability of any other provision. 
 9.12
Counterparts. This Agreement may be executed in counterparts, all of which together shall constitute one and the same instrument. 

 IN WITNESS WHEREOF, the Parties hereto have executed this Stock Purchase Agreement as of the
date and year first above written. 
  

									
	COMPANY:	 		 	EXA CORPORATION
					
		 		 		 	By:	 	/s/ Stephen A. Remondi
		 		 		 	Its:	 	President and CEO
			
	INVESTORS:	 		 	FIDELITY VENTURES LIMITED
					
		 		 		 	By:	 	Fidelity Capital Associates, Inc.
		 		 		 	Its:	 	Managing General Partner
					
		 		 		 	By:	 	/s/ [ILLEGIBLE]
		 		 		 	Its:	 	Vice President
			
		 		 	FIDELITY INVESTORS LIMITED PARTNERSHIP
					
		 		 		 	By:	 	Northern Neck Investors Corporation
		 		 		 	Its:	 	General Partner
					
		 		 		 	By:	 	/s/ [ILLEGIBLE]
		 		 		 	Its:	 	Chief Financial Officer

 
			
	BOSTON CAPITAL VENTURES III, LIMITED PARTNERSHIP
		
	By:	 	/s/ [ILLEGIBLE]
	Its:	 	General Partner
	
	BOSTON CAPITAL VENTURES IV, LIMITED PARTNERSHIP
		
	By:	 	/s/ John J. Shields, III
	Its:	 	General Partner

 Schedule A to Series I Stock Purchase Agreement 

 

									
	 	  	Series I Shares - Cash Financing	 
	 Investor Name and Address
	  	Number of Shares of Series I
Preferred Stock Purchased	 	  	Cash Consideration	 
	 Fidelity Ventures Limited

82 Devonshire Street

Boston, MA 02109-3614
	  	 	2,063,699	  	  	$	3,054,274.52	  
	 Fidelity Investors Limited Partnership

82 Devonshire Street

Boston, MA 02109-3614
	  	 	482,118	  	  	$	713,534.64	  
	 Boston Capital Ventures IV, L.P.

Attn: Charlie Bridge

84 State Street, Suite 320

Boston, MA 02109
	  	 	675,676	  	  	$	1,000,000.48	  
	 Worldwide Investment Services and Holdings, Inc.

c/o Richard J. Gaffey

Elder, Gaffey & Paine, P.C.,

171 Locke Dr.
 Marlborough, MA 01752
	  	 	60,220	  	  	$	89,125.60	  
	 James Popeo

42 Spruce Street
 North Reading, MA 01860
	  	 	59,191	  	  	$	87,602.68	  
	 Jean-Paul Roux

78 Avenue Anatole

Colombes, 92700 France
	  	 	15,177	  	  	$	22,461.96	  
	 John J. Shields, III

c/o Boston Capital Ventures

84 State Street, Suite 320

Boston, MA 02109
	  	 	11,369	  	  	$	16,826.12	  
	 King’s Point Holdings, Inc.

P.O. Box 174
 Prides Crossing, MA 01965
	  	 	5,545	  	  	$	8,206.60	  
	 Gerald B. Bay

27 Newport Street

Jamestown RI 02835
	  	 	5,385	  	  	$	7,969.80	  
	 Total
	  	 	3,378,380	  	  	$	5,000,002.40	  

													
	 	  	Note Shares - Debt Conversion	 
	 Investor Name and Address
	  	Number of Shares of
Series I Preferred
Stock Purchased	 	  	Number of Shares of
Common Stock
Purchased	 	  	 Cancellation of

Indebtedness

Under Non-

Convertible Notes
	 
	 Boston Capital Ventures III, L.P.

Attn: Charlie Bridge

84 State Street, Suite 320

Boston, MA 02109
	  	 	92,171	  	  	 	136,413	  	  	$	272,825.55	  
	 Boston Capital Ventures IV, L.P.

Attn: Charlie Bridge

84 State Street, Suite 320

Boston, MA 02109
	  	 	584,872	  	  	 	865,611	  	  	$	1,731,221.54	  
	 Total
	  	 	677,043	  	  	 	1,002,024	  	  	$	2,004,047.09	  

 Attachment 1 

EXA CORPORATION 
 SERIES I CONVERTIBLE PREFERRED STOCK 
 STOCK PURCHASE AGREEMENT 

Additional Investor 
 Counterpart Financing Signature Page 
 By executing this page in the space
provided, the undersigned investor hereby agrees (i) that it is an “Additional Investor” as defined in the Stock Purchase Agreement dated as of April 30th, 2008 among Exa Corporation and certain other parties named therein (the
“Series I SPA”), (ii) that it is a party to the Series I SPA for all purposes, and (iii) that it is bound by all of the terms and conditions of the Series I SPA. 

 

	
	Executed this 10 day of April, 2008
	
	James G. Popeo
	(print name)
	
	/s/ James G. Popeo
	(signature)
	By:
	Title:
	Address:
	
	Fax:

 Attachment 1 

EXA CORPORATION 
 SERIES I CONVERTIBLE PREFERRED STOCK 
 STOCK PURCHASE AGREEMENT 

Additional Investor 
 Counterpart Financing Signature Page 
 By executing this page in the space
provided, the undersigned investor hereby agrees (i) that it is an “Additional Investor” as defined in the Stock Purchase Agreement dated as of April 30th, 2008 among Exa Corporation and certain other parties named therein (the
“Series I SPA”), (ii) that it is a party to the Series I SPA for all purposes, and (iii) that it is bound by all of the terms and conditions of the Series I SPA. 

 

	
	Executed this 1st day of April, 2008
	
	King’s Point Holdings Inc.
	(print name)
	
	/s/ John J. Shields, III
	(signature)
	By: John J. Shields, III
	Title: President and CEO
	Address: 460 11th Ave. S Naples, FL 34102
	
	Fax:

 Attachment 1 

EXA CORPORATION 
 SERIES I CONVERTIBLE PREFERRED STOCK 
 STOCK PURCHASE AGREEMENT 

Additional Investor 
 Counterpart Financing Signature Page 
 By executing this page in the space
provided, the undersigned investor hereby agrees (i) that it is an “Additional Investor” as defined in the Stock Purchase Agreement dated as of April 30th, 2008 among Exa Corporation and certain other parties named therein (the
“Series I SPA”), (ii) that it is a party to the Series I SPA for all purposes, and (iii) that it is bound by all of the terms and conditions of the Series I SPA. 

 

	
	Executed this 1st day of April, 2008
	
	John J. Shields, III
	(print name)
	
	/s/ John J. Shields, III
	(signature)
	By:
	Title: Chairman John J. Shields, III
	Address: 460 11th Ave. S Naples, FL
	
	Fax:

 Attachment 1 

EXA CORPORATION 
 SERIES I CONVERTIBLE PREFERRED STOCK 
 STOCK PURCHASE AGREEMENT 

Additional Investor 
 Counterpart Financing Signature Page 
 By executing this page in the space
provided, the undersigned investor hereby agrees (i) that it is an “Additional Investor” as defined in the Stock Purchase Agreement dated as of April 30th, 2008 among Exa Corporation and certain other parties named therein (the
“Series I SPA”), (ii) that it is a party to the Series I SPA for all purposes, and (iii) that it is bound by all of the terms and conditions of the Series I SPA. 

 

	
	Executed this 29th day of April, 2008
	
	Worldwide Investment Services and Holdings, Inc.
	(print name)
	
	/s/ R.J. Gaffey
	(signature)
	By: R.J. Gaffey
	Title: Vice President
	Address: 171 Locke Drive Marlborough, MA 01752
	
	Fax:

 Attachment 1 

EXA CORPORATION 
 SERIES I CONVERTIBLE PREFERRED STOCK 
 STOCK PURCHASE AGREEMENT 

Additional Investor 
 Counterpart Financing Signature Page 
 By executing this page in the space
provided, the undersigned investor hereby agrees (i) that it is an “Additional Investor” as defined in the Stock Purchase Agreement dated as of April 30th, 2008 among Exa Corporation and certain other parties named therein (the
“Series I SPA”), (ii) that it is a party to the Series I SPA for all purposes, and (iii) that it is bound by all of the terms and conditions of the Series I SPA. 

 

	
	Executed this 24 day of April, 2008
	
	Gerald B. Bay
	(print name)
	
	/s/ Gerald B. Bay
	(signature)
	By:
	Title:
	Address: 27 Newport St. Jamestown, RI 02835
	
	Fax:

 Attachment 1 

EXA CORPORATION 
 SERIES I CONVERTIBLE PREFERRED STOCK 
 STOCK PURCHASE AGREEMENT 

Additional Investor 
 Counterpart Financing Signature Page 
 By executing this page in the space
provided, the undersigned investor hereby agrees (i) that it is an “Additional Investor” as defined in the Stock Purchase Agreement dated as of April 30th, 2008 among Exa Corporation and certain other parties named therein (the
“Series I SPA”), (ii) that it is a party to the Series I SPA for all purposes, and (iii) that it is bound by all of the terms and conditions of the Series I SPA. 

 

	
	Executed this 25 day of April, 2008
	
	Jean-Paul Roux
	(print name)
	
	/s/ Jean-Paul Roux
	(signature)
	By:
	Title: President Exa Eu Operations
	Address: 78, Avenue Anatole France 92.700 Colombes France
	
	Fax:Letter Agreement

 Exhibit 4.10 
 EXA CORPORATION 
 55 Network Drive 

Burlington, MA 01803 
 August 3, 2011 
 FMR LLC Fidelity Ventures Limited 

InfoTech Fund I LLC 
 82 Devonshire Street

 Boston, MA 02109 
 Boston Capital
Ventures, III, Limited Partnership 
 Boston Capital Partners, IV, Limited Partnership 
 84 State Street 
 Boston, MA 02109 
 Attention: Paul L. Mucci and Jack Shields 
  

	 	Re:	Agreement for Participation in Initial Public Offering 

 Gentlemen: 
 The undersigned Exa Corporation (“Exa”)
proposes to undertake a firm commitment underwritten initial public offering of its common stock (the “IPO”), with respect to which Stifel, Nicolaus & Company, Incorporated (“Stifel”) proposes
to act as representative of the several underwriters pursuant to an underwriting agreement in substantially the form heretofore presented to you (the “Underwriting Agreement”). 

To facilitate the IPO, Exa and Stifel have requested that each of FMR LLC, Fidelity Ventures Limited (“FVL”) and
InfoTech Fund I LLC, as successor to Fidelity Investors Limited Partnership (“FILP” and collectively with FMR LLC and FVL, the “FMR Entities”) and Boston Capital Ventures, III, Limited Partnership and
Boston Capital Partners, IV, Limited Partnership (collectively the “BCV Entities”), along with certain other shareholders of Exa, enter into (a) an Amendment, Consent and Waiver consenting to, among other things,
amendments to the certificate of incorporation and by-laws of Exa and waiver of certain rights of the holders of Exa’s outstanding preferred stock with respect to registration of Exa securities held by them, and (b) a Lock-up Agreement in
a form requested by Stifel. We understand that the willingness of the FMR Entities and the BCV Entities to execute the foregoing documents is conditional upon Exa’s undertakings set forth in this Agreement. 

In consideration of the execution and delivery by the FMR Entities and the BCV Entities of the Amendment, Consent and Waiver and the
Lock-Up Agreement referred to above, Exa agrees with you as follows: 

 1. Capitalized terms used and not otherwise defined in this letter agreement will have the
meanings set forth in the Stock Purchase Agreement dated April 30, 2008 among Exa, FVL, FILP and certain other (the “Series I Purchase Agreement”). References to shares of Exa common stock $.001 par value
(“Common Stock”), assume the conversion to Common Stock in accordance with their terms of all outstanding shares of Exa’s preferred stock, but do not give effect to the reverse split contemplated with respect to
Exa’s Common Stock. 
 2. Exa covenants and agrees that it will not circulate to prospective investors any preliminary
prospectus for Exa’s initial public offering (whether pursuant to the Underwriting Agreement or any other underwriting agreement) that discloses an expected initial public offering price or range of expected initial public offering prices
unless the holders of at least 70% of the then outstanding shares of Preferred Stock (the “Requisite Holders”) shall have consented in writing to (a) the minimum initial public offering price per share price stated in
such range, (b) the numbers of shares to be offered by each of Exa, the FMR Entities and the BCV Entities and (c) the gross proceeds of the offering, each as set forth in such preliminary prospectus. 

Exa further covenants and agrees that without the written consent of the Requisite Holders, (x) the price per share for each share
of Common Stock sold in the IPO, as set forth in the final prospectus for the IPO, will not be (a) lower than 90% of the price that is the low end of the range of the set forth in the latest preliminary prospectus approved by the Requisite
Holders, or (b) greater than 110% of the price that is the high end of the range set forth in the latest preliminary prospectus approved by the Requisite Holders, (y) the aggregate number of Firm Shares offered in the IPO will not be
(a) fewer than 80% of the aggregate number of shares to be offered as set forth in the latest preliminary prospectus approved by the Requisite Holders or (b) more than 120% of the aggregate number of shares to be offered as set forth in
the latest preliminary prospectus approved by the Requisite Holders, and (z) the number of shares of Common Stock held by the FMR Entities included as Firm Shares in the Underwriting Agreement shall not be less than such number of shares of
Common Stock held by the FMR Entities set forth in the latest preliminary prospectus approved by the Requisite Holders (the “FMR Registrable Securities”). 

3. Exa agrees to use its best efforts to prepare, file with the SEC and cause to become effective a registration statement on Form S-1
with respect to the IPO (the “Registration Statement”), and, notwithstanding any provision of Section 8.3 of the Series I Purchase Agreement to the contrary, to include in the Registration Statement: 

 

	 	a.	the FMR Registrable Securities, and 

  

	 	b.	provided that the FMR Registrable Securities shall have been so included, to include such number of shares of Common Stock held by the BCV Entities (the “BCV
Registrable Securities”) as the BCV Entities shall request, subject to any determination by Stifel, in its sole judgment, that due to marketing considerations it is necessary to limit the number of shares allowed to participate in the
IPO which are not being sold for the account of Exa and/or the FMR Entities. 

  
 2 

 4. Except as otherwise expressly set forth herein, the terms upon which the FMR Registrable
Securities and BCV Registrable Securities will be included in the Registration Statement shall be as set forth in Sections 8.5, 8.6, 8.7, 8.8, 8.11 and 8.12 of the Series I Purchase Agreement. For the avoidance of doubt, Sections 8.1, 8.2, 8.4,
8.9, 8.10 and 8.13 of the Series I Purchase Agreement shall remain in full force and effect, except as effectively waived in writing. 
 5. Without limiting the generality of the foregoing, all expenses of the IPO and the inclusion of the FMR Registrable Securities and BCV Registrable Securities in the Registration Statement, other than
the underwriters’ discount or commission and the fees and expenses of counsel to the FMR Entities and BCV Entities, shall be borne by Exa. 
 6. In the event that the FMR Entities consent to include in the final prospectus a number of shares of Common Stock that is less than the number of FMR Registrable Securities that was included in the
latest preliminary prospectus consented to by the Requisite Holders, then Exa will use its best efforts to include in the Underwriting Agreement as Option Shares (as defined in the Underwriting Agreement), to be sold in the event of the exercise of
the underwriters’ overallotment option, (a) such additional number of shares of Common Stock held by the FMR Entities as is necessary such that, upon sale of all the Firm Shares and Option Shares, all FMR Registrable Securities will have
been sold, or (b) if less, the maximum number of shares that Stifel shall determine may be included as Option Shares in the IPO. 
 7. The provisions of sections 9.4, 9.6, 9.7 and 9.8 of the Series I Purchase Agreement shall apply to this letter agreement. This letter agreement (including such portions of the Series I Purchase
Agreement as are expressly incorporated by reference herein) constitutes the entire agreement among Exa, the FMR Entities and the BCV Entities solely with respect to the subject matter hereof, and supersedes any prior agreement between them with
respect to registration of any Registrable Securities held by the FMR Entities or the BCV Entities in the IPO. 
 8. This
Agreement shall expire and become null and void in the event that an underwriting agreement with respect to Exa’s initial public offering shall not have been executed by March 31, 2012. 

To confirm that this letter sets forth our agreement, kindly execute a copy of this letter where indicated below and return it to me.

  
 3 

 We appreciate the continued support of the FMR Entities and the BCV Entities for Exa and the
IPO process. 
  

	
	 Sincerely,
  
 EXA CORPORATION

	
	/s/ Stephen Remondi
	 Stephen Remondi
 Chief
Executive Officer

  

	cc:	John D. Patterson, Jr., Esq. 

	    	Robert W. Sweet, Jr., Esq. 

	    	David Goldman, Esq. 

	    	Joel Rubinstein, Esq. 

	    	Meir Lewittes, Esq. 

  

			
	FMR LLC
		
	By	 	/s/ Steven F. Schiffin

  
  

			
	FIDELITY VENTURES LIMITED
		
	By:	 	Fidelity Capital Associates, Inc. Its Managing General Partner
		
	By	 	/s/ Paul L. Mucci

  
 4 

			
	INFOTECH FUND I LLC
		
	By:	 	 Star Horizon Management LLC

Its Manager

		
	By	 	/s/ Paul L. Mucci

  
  

			
	BOSTON CAPITAL VENTURES III, LIMITED PARTNERSHIP
		
	By	 	/s/ Johan van der Goltz

  
  

			
	BOSTON CAPITAL VENTURES IV, LIMITED PARTNERSHIP
		
	By	 	/s/ John J. Shields, III
		 	

  
 5

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00192-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00192-of-00352.parquet"}]]